Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 715190, 14 pages
http://dx.doi.org/10.1155/2012/715190
Review Article

Immunopathological Roles of Cytokines, Chemokines, Signaling Molecules, and Pattern-Recognition Receptors in Systemic Lupus Erythematosus

1Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong
2Department of Rheumatology, Hospital Selayang, Lebuhraya Selayang-Kepong, 68100 Batu Caves, Malaysia
3Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong

Received 12 July 2011; Accepted 11 October 2011

Academic Editor: Philip Alex

Copyright © 2012 Shui-Lian Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. D. Heinlen, M. T. McClain, J. Merrill et al., “Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms,” Arthritis and Rheumatism, vol. 56, no. 7, pp. 2344–2351, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. F. Viallard, J. L. Pellegrin, V. Ranchin et al., “Th1 (IL-2, interferon-gamma (IFN-γ)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE),” Clinical and Experimental Immunology, vol. 115, no. 1, pp. 189–195, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Miyake, M. Akahoshi, and H. Nakashima, “Th subset balance in lupus nephritis,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 980286, 2011. View at Google Scholar
  4. C. Mohan, S. Adams, V. Stanik, and S. K. Datta, “Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus,” Journal of Experimental Medicine, vol. 177, no. 5, pp. 1367–1381, 1993. View at Google Scholar · View at Scopus
  5. Y. Tokano, S. Morimoto, H. Kaneko et al., “Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)—relation to Th1- and Th2-derived cytokines,” Clinical and Experimental Immunology, vol. 116, no. 1, pp. 169–173, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. Davas, A. Tsirogianni, I. Kappou, D. Karamitsos, I. Economidou, and P. C. Dantis, “Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α levels and disease activity in systemic lupus erythematosus,” Clinical Rheumatology, vol. 18, no. 1, pp. 17–22, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Al-Janadi, S. Al-Balla, A. Al-Dalaan, and S. Raziuddin, “Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases,” Journal of Clinical Immunology, vol. 13, no. 1, pp. 58–67, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Apostolidis, L. A. Lieberman, K. Kis-Toth, J. C. Crispin, and G. C. Tsokos, “The dysregulation of cytokine networks in systemic lupus erythematosus,” Journal of Interferon and Cytokine Research, vol. 31, no. 10, pp. 769–779, 2011. View at Publisher · View at Google Scholar · View at PubMed
  9. C. L. Langrish, B. S. McKenzie, N. J. Wilson, R. De Waal Malefyt, R. A. Kastelein, and D. J. Cua, “IL-12 and IL-23: master regulators of innate and adaptive immunity,” Immunological Reviews, vol. 202, pp. 96–105, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. G. Trinchieri, “Interleukin-12 and the regulation of innate resistance and adaptive immunity,” Nature Reviews Immunology, vol. 3, no. 2, pp. 133–146, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. R. Kitching, A. L. Turner, G. R. A. Wilson et al., “IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment,” Journal of the American Society of Nephrology, vol. 16, no. 7, pp. 2023–2033, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. X. Huang, J. Hua, N. Shen, and S. Chen, “Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients,” Modern Rheumatology, vol. 17, no. 3, pp. 220–223, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. K. Wong, C. Y. Ho, E. K. Li, and C. W. K. Lam, “Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus,” Lupus, vol. 9, no. 8, pp. 589–593, 2000. View at Google Scholar · View at Scopus
  14. S. Aggarwal, N. Ghilardi, M. H. Xie, F. J. De Sauvage, and A. L. Gurney, “Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 1910–1914, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. Y. Tsai, T. H. Wu, C. L. Yu, Y. Y. Tsai, and C. T. Chou, “Decreased IL-12 production by polymorphonuclear leukocytes in patients with active systemic lupus erythematosus,” Immunological Investigations, vol. 31, no. 3-4, pp. 177–189, 2002. View at Google Scholar · View at Scopus
  16. C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. M. Li, P. T. Y. Wong, and C. W. K. Lam, “Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity,” Clinical Immunology, vol. 127, no. 3, pp. 385–393, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. C. S. R. Lankford and D. M. Frucht, “A unique role for IL-23 in promoting cellular immunity,” Journal of Leukocyte Biology, vol. 73, no. 1, pp. 49–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Chen, C. M. Tato, L. Muul, A. Laurence, and J. J. O'Shea, “Distinct regulation of interleukin-17 in human T helper lymphocytes,” Arthritis and Rheumatism, vol. 56, no. 9, pp. 2936–2946, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. A. Hoeve, N. D. L. Savage, T. de Boer et al., “Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells,” European Journal of Immunology, vol. 36, no. 3, pp. 661–670, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. A. R. Gocke, P. D. Cravens, L. H. Ben et al., “T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity,” Journal of Immunology, vol. 178, no. 3, pp. 1341–1348, 2007. View at Google Scholar · View at Scopus
  21. J. Furuzawa-Carballeda, M. I. Vargas-Rojas, and A. R. Cabral, “Autoimmune inflammation from the Th17 perspective,” Autoimmunity Reviews, vol. 6, no. 3, pp. 169–175, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. E. Bettelli, M. Oukka, and V. K. Kuchroo, “TH-17 cells in the circle of immunity and autoimmunity,” Nature Immunology, vol. 8, no. 4, pp. 345–350, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. C. A. Dinarello, “IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family,” Journal of Allergy and Clinical Immunology, vol. 103, no. 1, pp. 11–24, 1999. View at Google Scholar · View at Scopus
  24. T. Hoshino, R. H. Wiltrout, and H. A. Young, “IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response,” Journal of Immunology, vol. 162, no. 9, pp. 5070–5077, 1999. View at Google Scholar · View at Scopus
  25. T. Yoshimoto, H. Mizutani, H. Tsutsui et al., “IL-I 8 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6,” Nature Immunology, vol. 1, no. 2, pp. 132–137, 2000. View at Google Scholar · View at Scopus
  26. T. A. Fehniger, M. H. Shah, M. J. Turner et al., “Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response,” Journal of Immunology, vol. 162, no. 8, pp. 4511–4520, 1999. View at Google Scholar · View at Scopus
  27. C. K. Wong, E. K. Li, C. Y. Ho, and C. W. K. Lam, “Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus,” Rheumatology, vol. 39, no. 10, pp. 1078–1081, 2000. View at Google Scholar · View at Scopus
  28. P. Amerio, A. Frezzolini, D. Abeni et al., “Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines,” Clinical and Experimental Rheumatology, vol. 20, no. 4, pp. 535–538, 2002. View at Google Scholar · View at Scopus
  29. K. Shibatomi, H. Ida, S. Yamasaki et al., “A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases,” Arthritis and Rheumatism, vol. 44, no. 4, pp. 884–892, 2001. View at Google Scholar · View at Scopus
  30. C. R. Parikh, A. Jani, V. Y. Melnikov, S. Faubel, and C. L. Edelstein, “Urinary interleukin-18 is a marker of human acute tubular necrosis,” American Journal of Kidney Diseases, vol. 43, no. 3, pp. 405–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. C. R. Parikh, A. Jani, J. Mishra et al., “Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation,” American Journal of Transplantation, vol. 6, no. 7, pp. 1639–1645, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. F. Favilli, C. Anzilotti, L. Martinelli et al., “IL-18 activity in systemic lupus erythematosus,” Annals of the New York Academy of Sciences, vol. 1173, pp. 301–309, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. D. Neumann, E. Del Giudice, A. Ciaramella, D. Boraschi, and P. Bossù, “Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain,” Journal of Immunology, vol. 166, no. 6, pp. 3757–3762, 2001. View at Google Scholar · View at Scopus
  34. R. I. Nurieva, Y. Chung, D. Hwang et al., “Generation of T follicular helper cells is mediated by interleukin-21 but independent of T Helper 1, 2, or 17 cell lineages,” Immunity, vol. 29, no. 1, pp. 138–149, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. R. Spolski and W. J. Leonard, “Interleukin-21: basic biology and implications for cancer and autoimmunity,” Annual Review of Immunology, vol. 26, pp. 57–79, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. Vogelzang, H. M. McGuire, D. Yu, J. Sprent, C. R. Mackay, and C. King, “A fundamental role for interleukin-21 in the generation of T follicular helper cells,” Immunity, vol. 29, no. 1, pp. 127–137, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. C. King, S. G. Tangye, and C. R. Mackay, “T follicular helper (TFH) cells in normal and dysregulated immune responses,” Annual Review of Immunology, vol. 26, pp. 741–766, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. A. H. Sawalha, K. M. Kaufman, J. A. Kelly et al., “Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 458–461, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. J. A. Bubier, T. J. Sproule, O. Foreman et al., “A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1518–1523, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. A. Linterman, R. J. Rigby, R. K. Wong et al., “Follicular helper T cells are required for systemic autoimmunity,” Journal of Experimental Medicine, vol. 206, no. 3, pp. 561–576, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. C. A. Dinarello, “Interleukin-1,” Cytokine and Growth Factor Reviews, vol. 8, no. 4, pp. 253–265, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Xu, H. R. Jiang, P. Kewin et al., “IL-33 exacerbates antigen-induced arthritis by activating mast cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 31, pp. 10913–10918, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. Z. Yang, Y. Liang, W. Xi, C. Li, and R. Zhong, “Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population,” Clinical and Experimental Medicine, vol. 11, no. 2, pp. 75–80, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. M. Y. Mok, F. P. Huang, W. K. Ip et al., “Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus,” Rheumatology, vol. 49, no. 3, Article ID kep402, pp. 520–527, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. H. E. Barksby, S. R. Lea, P. M. Preshaw, and J. J. Taylor, “The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders,” Clinical and Experimental Immunology, vol. 149, no. 2, pp. 217–225, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. F. Y. Liew, N. I. Pitman, and I. B. McInnes, “Disease-associated functions of IL-33: the new kid in the IL-1 family,” Nature Reviews Immunology, vol. 10, no. 2, pp. 103–110, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. J. Schmitz, A. Owyang, E. Oldham et al., “IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines,” Immunity, vol. 23, no. 5, pp. 479–490, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. M. Löhning, A. Stroehmann, A. J. Coyle et al., “T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 6930–6935, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Kuroiwa, T. Arai, H. Okazaki, S. Minota, and S. I. Tominaga, “Identification of human ST2 protein in the sera of patients with autoimmune diseases,” Biochemical and Biophysical Research Communications, vol. 284, no. 5, pp. 1104–1108, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. R. W. Y. Chan, F. M. M. Lai, E. K. M. Li et al., “Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis,” Rheumatology, vol. 45, no. 8, pp. 951–957, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher, “A novel transcription factor, T-bet, directs Th1 lineage commitment,” Cell, vol. 100, no. 6, pp. 655–669, 2000. View at Google Scholar · View at Scopus
  52. D. H. Zhang, L. Yang, and A. Ray, “Cutting edge: differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3,” Journal of Immunology, vol. 161, no. 8, pp. 3817–3821, 1998. View at Google Scholar · View at Scopus
  53. W. Ouyang, M. Löhning, Z. Gao et al., “Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment,” Immunity, vol. 12, no. 1, pp. 27–37, 2000. View at Google Scholar · View at Scopus
  54. G. R. Lee, P. E. Fields, and R. A. Flavell, “Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level,” Immunity, vol. 14, no. 4, pp. 447–459, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. L. C. W. Lit, C. K. Wong, E. K. M. Li, L. S. Tam, C. W. K. Lam, and Y. M. D. Lo, “Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus,” Journal of Rheumatology, vol. 34, no. 1, pp. 89–96, 2007. View at Google Scholar · View at Scopus
  56. L. A. Garrett-Sinha, S. John, and S. L. Gaffen, “IL-17 and the Th17 lineage in systemic lupus erythematosus,” Current Opinion in Rheumatology, vol. 20, no. 5, pp. 519–525, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. E. Lubberts, “IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?” Cytokine, vol. 41, no. 2, pp. 84–91, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. C. Dong, “TH17 cells in development: an updated view of their molecular identity and genetic programming,” Nature Reviews Immunology, vol. 8, no. 5, pp. 337–348, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. N. Manel, D. Unutmaz, and D. R. Littman, “The differentiation of human TH17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt,” Nature Immunology, vol. 9, no. 6, pp. 641–649, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T Helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. E. Rouvier, M. F. Luciani, M. G. Mattei, F. Denizot, and P. Golstein, “CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene,” Journal of Immunology, vol. 150, no. 12, pp. 5445–5456, 1993. View at Google Scholar · View at Scopus
  62. J. K. Kolls and A. Lindén, “Interleukin-17 family members and inflammation,” Immunity, vol. 21, no. 4, pp. 467–476, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. A. Nalbandian, J. C. Crispín, and G. C. Tsokos, “Interleukin-17 and systemic lupus erythematosus: current concepts,” Clinical and Experimental Immunology, vol. 157, no. 2, pp. 209–215, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. J. C. Crispín, M. Oukka, G. Bayliss et al., “Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys,” Journal of Immunology, vol. 181, no. 12, pp. 8761–8766, 2008. View at Google Scholar · View at Scopus
  65. G. Dong, R. Ye, W. Shi et al., “IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients,” Chinese Medical Journal, vol. 116, no. 4, pp. 543–548, 2003. View at Google Scholar · View at Scopus
  66. K. Kurasawa, K. Hirose, H. Sano et al., “Increased interleukin-17 production in patients with systemic sclerosis,” Arthritis and Rheumatism, vol. 43, no. 11, pp. 2455–2463, 2000. View at Google Scholar · View at Scopus
  67. S. Dolff, M. Bijl, M. G. Huitema, P. C. Limburg, C. G.M. Kallenberg, and W. H. Abdulahad, “Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus,” Clinical Immunology, vol. 141, no. 2, pp. 197–207, 2011. View at Publisher · View at Google Scholar · View at PubMed
  68. A. B. Pernis, “Th17 cells in rheumatoid arthritis and systemic lupus erythematosus,” Journal of Internal Medicine, vol. 265, no. 6, pp. 644–652, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. H. C. Hsu, P. A. Yang, J. Wang et al., “Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice,” Nature Immunology, vol. 9, no. 2, pp. 166–175, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. H. K. Kang, M. Liu, and S. K. Datta, “Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells,” Journal of Immunology, vol. 178, no. 12, pp. 7849–7858, 2007. View at Google Scholar · View at Scopus
  71. A. Zlotnik and O. Yoshie, “Chemokines: a new classification system and their role in immunity,” Immunity, vol. 12, no. 2, pp. 121–127, 2000. View at Google Scholar · View at Scopus
  72. F. Sallusto and A. Lanzavecchia, “Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression,” Immunological Reviews, vol. 177, pp. 134–140, 2000. View at Google Scholar · View at Scopus
  73. B. A. Premack and T. J. Schall, “Chemokine receptors: gateways to inflammation and infection,” Nature Medicine, vol. 2, no. 11, pp. 1174–1178, 1996. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Sallusto, “The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses,” Haematologica, vol. 84, pp. 28–31, 1999. View at Google Scholar · View at Scopus
  75. R. W. Hoffman, “T cells in the pathogenesis of systemic lupus erythematosus,” Frontiers in Bioscience, vol. 6, pp. D1369–D1378, 2001. View at Google Scholar · View at Scopus
  76. K. J. Katschke Jr., J. B. Rottman, J. H. Ruth et al., “Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 44, no. 5, pp. 1022–1032, 2001. View at Google Scholar · View at Scopus
  77. C. L. Galligan, W. Matsuyama, A. Matsukawa et al., “Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 50, no. 6, pp. 1806–1814, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. H. Bartosik-Psujek, E. Belniak, K. Mitosek-Szewczyk, B. Dobosz, and Z. Stelmasiak, “Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine,” Acta Neurologica Scandinavica, vol. 109, no. 6, pp. 390–392, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. K. M. Ansel, R. B. S. Harris, and J. G. Cyster, “CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity,” Immunity, vol. 16, no. 1, pp. 67–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. J. L. M. Vissers, F. C. Hartgers, E. Lindhout, C. G. Figdor, and G. J. Adema, “BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo,” European Journal of Immunology, vol. 31, no. 5, pp. 1544–1549, 2001. View at Google Scholar · View at Scopus
  81. D. F. Legler, M. Loetscher, R. S. Roos, I. Clark-Lewis, M. Baggiolini, and B. Moser, “B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5,” Journal of Experimental Medicine, vol. 187, no. 4, pp. 655–660, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Hayakawa and R. R. Hardy, “Development and function of B-1 cells,” Current Opinion in Immunology, vol. 12, no. 3, pp. 346–354, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Sato, S. Ishikawa, K. Akadegawa et al., “Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus,” European Journal of Immunology, vol. 34, no. 12, pp. 3346–3358, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. M. Dauphinee, Z. Tovar, and N. Talal, “B cells expressing CD5 are increased in Sjogren's syndrome,” Arthritis and Rheumatism, vol. 31, no. 5, pp. 642–647, 1988. View at Google Scholar · View at Scopus
  85. C. Plater-Zyberk, R. N. Maini, K. Lam, T. D. Kennedy, and G. Janossy, “A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia,” Arthritis and Rheumatism, vol. 28, no. 9, pp. 971–976, 1985. View at Google Scholar · View at Scopus
  86. T. Ito, S. Ishikawa, T. Sato et al., “Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus,” Journal of Immunology, vol. 172, no. 6, pp. 3628–3634, 2004. View at Google Scholar · View at Scopus
  87. S. Ishikawa, T. Sato, M. Abe et al., “Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC,” Journal of Experimental Medicine, vol. 193, no. 12, pp. 1393–1402, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Ishikawa and K. Matsushima, “Aberrant B1 cell trafficking in a murine model for lupus,” Frontiers in Bioscience, vol. 12, no. 5, pp. 1790–1803, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. P. Schaerli, K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, and B. Moser, “CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function,” Journal of Experimental Medicine, vol. 192, no. 11, pp. 1553–1562, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Breitfeld, L. Ohl, E. Kremmer et al., “Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production,” Journal of Experimental Medicine, vol. 192, no. 11, pp. 1545–1551, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. N. Fazilleau, L. Mark, L. J. McHeyzer-Williams, and M. G. McHeyzer-Williams, “Follicular Helper T cells: lineage and location,” Immunity, vol. 30, no. 3, pp. 324–335, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. C. G. Vinuesa, S. G. Tangye, B. Moser, and C. R. Mackay, “Follicular B helper T cells in antibody responses and autoimmunity,” Nature Reviews Immunology, vol. 5, no. 11, pp. 853–865, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. C. K. Wong, P. T. Y. Wong, L. S. Tam, E. K. Li, D. P. Chen, and C. W. K. Lam, “Elevated production of B Cell Chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity,” Journal of Clinical Immunology, vol. 30, no. 1, pp. 45–52, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. L. Schiffer, P. Kümpers, A. M. Davalos-Misslitz et al., “B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE),” Nephrology Dialysis Transplantation, vol. 24, no. 12, pp. 3708–3712, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. I. Rioja, F. J. Hughes, C. H. Sharp et al., “Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor,” Arthritis and Rheumatism, vol. 58, no. 8, pp. 2257–2267, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. P. Loetscher, M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. Moser, “Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes,” FASEB Journal, vol. 8, no. 13, pp. 1055–1060, 1994. View at Google Scholar · View at Scopus
  97. H. Nakajima, M. Kobayashi, R. B. Pollard, and F. Suzuki, “Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses,” Journal of Leukocyte Biology, vol. 70, no. 3, pp. 374–380, 2001. View at Google Scholar · View at Scopus
  98. H. Kaneko, H. Ogasawara, T. Naito et al., “Circulating levels of β-chemokines in systemic lupus erythematosus,” Journal of Rheumatology, vol. 26, no. 3, pp. 568–573, 1999. View at Google Scholar · View at Scopus
  99. N. Iikuni, H. Okamoto, T. Yoshio et al., “Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus,” Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 253–256, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. T. J. Schall, K. Bacon, K. J. Toy, and D. V. Goeddel, “Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES,” Nature, vol. 347, no. 6294, pp. 669–671, 1990. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. L. C. W. Lit, C. K. Wong, L. S. Tam, E. K. M. Li, and C. W. K. Lam, “Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 209–215, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. X. Zhao, Y. Tang, B. Qu et al., “MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 62, no. 11, pp. 3425–3435, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. V. Eis, B. Luckow, V. Vielhauer et al., “Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction,” Journal of the American Society of Nephrology, vol. 15, no. 2, pp. 337–347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. K. J. Moore, T. Wada, S. D. Barbee, and V. R. Kelley, “Gene transfer of RANTES elicits autoimmune renal injury in MRL-Faslpr mice,” Kidney International, vol. 53, no. 6, pp. 1631–1641, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. R. W. Y. Chan, L. S. Tam, E. K. M. Li et al., “Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis,” Arthritis and Rheumatism, vol. 48, no. 5, pp. 1326–1331, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. B. H. Rovin, H. Song, D. J. Birmingham, L. A. Hebert, C. Y. Yu, and H. N. Nagaraja, “Urine chemokines as biomarkers of human systemic lupus erythematosus activity,” Journal of the American Society of Nephrology, vol. 16, no. 2, pp. 467–473, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. M. Baggiolini, B. Dewald, and B. Moser, “Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines,” Advances in Immunology, vol. 55, pp. 97–179, 1994. View at Google Scholar · View at Scopus
  108. E. Y. Lee, Z. H. Lee, and Y. W. Song, “CXCL10 and autoimmune diseases,” Autoimmunity Reviews, vol. 8, no. 5, pp. 379–383, 2009. View at Publisher · View at Google Scholar · View at PubMed
  109. S. Gasperini, M. Marchi, F. Calzetti et al., “Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell α chemoattractant (I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils,” Journal of Immunology, vol. 162, no. 8, pp. 4928–4937, 1999. View at Google Scholar · View at Scopus
  110. S. Narumi, T. Takeuchi, Y. Kobayashi, and K. Konishi, “Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus,” Cytokine, vol. 12, no. 10, pp. 1561–1565, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  111. L. C. W. Lit, C. K. Wong, L. S. Tam, E. K. M. Li, and C. W. K. Lam, “Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 65, no. 2, pp. 209–215, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  112. H. Okamoto, N. Iikuni, S. Kamitsuji, T. Yoshio, S. Minota, and N. Kamatani, “IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients,” Rheumatology, vol. 45, no. 2, pp. 232–234, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  113. H. Okamoto, Y. Katsumata, K. Nishimura, and N. Kamatani, “Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3731–3732, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. T. Matsumiya, T. Imaizumi, H. Itaya et al., “Production of growth related oncogene protein-α in human umbilical vein endothelial cells stimulated with soluble interleukin-6 receptor-α: role of signal transducers, janus kinase 2 and mitogen-activated kinase kinase,” Life Sciences, vol. 70, no. 26, pp. 3179–3190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. P. Pantelidis, A. M. Southcott, C. M. Black, and R. M. Du Bois, “Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis,” Clinical and Experimental Immunology, vol. 108, no. 1, pp. 95–104, 1997. View at Google Scholar · View at Scopus
  116. M. B. Bolster, A. Ludwicka, S. E. Sutherland, C. Strange, and R. M. Silver, “Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis,” Arthritis and Rheumatism, vol. 40, no. 4, pp. 743–751, 1997. View at Publisher · View at Google Scholar · View at Scopus
  117. C. K. Wong, W. K. Ip, and C. W. K. Lam, “Biochemical assessment of intracellular signal transduction pathways in eosinophils: implications for pharmacotherapy,” Critical Reviews in Clinical Laboratory Sciences, vol. 41, no. 1, pp. 79–113, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  118. L. Chang and M. Karin, “Mammalian MAP kinase signalling cascades,” Nature, vol. 410, no. 6824, pp. 37–40, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. P. F. Y. Cheung, C. K. Wong, W. K. Ip, and C. W. K. Lam, “IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation,” Allergy, vol. 61, no. 7, pp. 878–885, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. C. K. Wong, P. F. Y. Cheung, W. K. Ip, and C. W. K. Lam, “Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-κB,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 2, pp. 186–194, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  121. C. K. Wong, P. W. Li, and C. W. K. Lam, “Intracellular JNK, p38 MAPK and NF-κB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes,” Immunology Letters, vol. 112, no. 2, pp. 82–91, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. G. A. Bishop, Y. Hsing, B. S. Hostager, S. V. Jalukar, L. M. Ramirez, and M. A. Tomai, “Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848,” Journal of Immunology, vol. 165, no. 10, pp. 5552–5557, 2000. View at Google Scholar · View at Scopus
  123. K. Yoshimoto, Y. Takahashi, M. Ogasawara et al., “Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy,” International Immunology, vol. 18, no. 7, pp. 1189–1196, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. S. L. Peng, A. J. Gerth, A. M. Ranger, and L. H. Glimcher, “NFATc1 and NFATc2 together control both T and B cell activation and differentiation,” Immunity, vol. 14, no. 1, pp. 13–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. F. Pessler, L. Dai, R. Q. Cron, and H. R. Schumacher, “NFAT transcription factors - New players in the pathogenesis of inflammatory arthropathies?” Autoimmunity Reviews, vol. 5, no. 2, pp. 106–110, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. H. K. Wong, G. M. Kammer, G. Dennis, and G. C. Tsokos, “Abnormal NF-κB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression,” Journal of Immunology, vol. 163, no. 3, pp. 1682–1689, 1999. View at Google Scholar · View at Scopus
  127. S. Gorjestani, V. Rider, B. F. Kimler, C. Greenwell, and N. I. Abdou, “Extracellular signal-regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity,” Lupus, vol. 17, no. 6, pp. 548–554, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  128. S. N. C. Liossis, E. E. Solomou, M. A. Dimopoulos, P. Panayiotidis, M. M. Mavrikakis, and P. P. Sfikakis, “B-cell kinase lyn deficiency in patients with systemic lupus erythematosus,” Journal of Investigative Medicine, vol. 49, no. 2, pp. 157–165, 2001. View at Google Scholar · View at Scopus
  129. E. C. Jury, P. S. Kabouridis, A. Abba, R. A. Mageed, and D. A. Isenberg, “Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 48, no. 5, pp. 1343–1354, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. C. Deng, M. J. Kaplan, J. Yang et al., “Decreased ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients,” Arthritis and Rheumatism, vol. 44, no. 2, pp. 397–407, 2001. View at Google Scholar · View at Scopus
  131. C. K. Wong, P. T. Y. Wong, L. S. Tam, E. K. Li, D. P. Chen, and C. W. K. Lam, “Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus,” Journal of Clinical Immunology, vol. 29, no. 6, pp. 738–746, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  132. R. Verdolini, L. Bugatti, M. Giangiacomi, M. Nicolini, G. Filosa, and R. Cerio, “Systemic lupus erythematosus induced by Epstein-Barr virus infection,” British Journal of Dermatology, vol. 146, no. 5, pp. 877–881, 2002. View at Publisher · View at Google Scholar · View at Scopus
  133. H. Tomita, M. Yamada, I. Sekigawa, T. Yoshiike, N. Iida, and H. Hashimoto, “Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection,” Clinical and Experimental Rheumatology, vol. 21, no. 4, pp. 497–499, 2003. View at Google Scholar · View at Scopus
  134. M. R. Lerner, N. C. Andrews, G. Miller, and J. A. Steitz, “Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 2, pp. 805–809, 1981. View at Google Scholar · View at Scopus
  135. T. Kawai and S. Akira, “Innate immune recognition of viral infection,” Nature Immunology, vol. 7, no. 2, pp. 131–137, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. D. Werling and T. W. Jungi, “TOLL-like receptors linking innate and adaptive immune response,” Veterinary Immunology and Immunopathology, vol. 91, no. 1, pp. 1–12, 2003. View at Publisher · View at Google Scholar
  137. M. Yamamoto, S. Sato, H. Hemmi et al., “Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway,” Science, vol. 301, no. 5633, pp. 640–643, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  138. M. Fischer and M. Ehlers, “Toll-like receptors in autoimmunity,” Annals of the New York Academy of Sciences, vol. 1143, pp. 21–34, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. L. A. J. O'Neill, “The interleukin-1 receptor/Toll-like receptor superfamily: 10 Years of progress,” Immunological Reviews, vol. 226, no. 1, pp. 10–18, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology, vol. 21, pp. 335–376, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. A. Sadanaga, H. Nakashima, M. Akahoshi et al., “Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice,” Arthritis and Rheumatism, vol. 56, no. 5, pp. 1618–1628, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. R. D. Pawar, A. Ramanjaneyulu, O. P. Kulkarni, M. Lech, S. Segerer, and H. J. Anders, “Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus,” Journal of the American Society of Nephrology, vol. 18, no. 6, pp. 1721–1731, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. S. R. Christensen, J. Shupe, K. Nickerson, M. Kashgarian, R. Flavell, and M. J. Shlomchik, “Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus,” Immunity, vol. 25, no. 3, pp. 417–428, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. M. Ehlers, H. Fukuyama, T. L. McGaha, A. Aderem, and J. V. Ravetch, “TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE,” Journal of Experimental Medicine, vol. 203, no. 3, pp. 553–561, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  145. H. Poeck, M. Wagner, J. Battiany et al., “Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help,” Blood, vol. 103, no. 8, pp. 3058–3064, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  146. E. D. Papadimitraki, C. Choulaki, E. Koutala et al., “Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process,” Arthritis and Rheumatism, vol. 54, no. 11, pp. 3601–3611, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. A. Komatsuda, H. Wakui, K. Iwamoto et al., “Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 152, no. 3, pp. 482–487, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. C. K. Wong, P. T. Wong, L. S. Tam, E. K. Li, D. P. Chen, and C. W. Lam, “Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 159, no. 1, pp. 11–22, 2010. View at Publisher · View at Google Scholar · View at PubMed
  149. P. K. C. S. L. Yu, C. K. Wong, C. C. Szeto, and S. C. Ho, “Antagonist-mediated down-regulation of the expression of intracellular toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. Abstract of the European league against rheumatism annual congress,” Annals of the Rheumatic Diseases, vol. 70, supplement 3, p. 529, 2011. View at Google Scholar
  150. N. Inohara, M. Chamaillard, C. McDonald, and G. Nuñez, “NOD-LRR proteins: role in host-microbial interactions and inflammatory disease,” Annual Review of Biochemistry, vol. 74, pp. 355–383, 2005. View at Publisher · View at Google Scholar · View at PubMed
  151. T. A. Kufer, J. H. Fritz, and D. J. Philpott, “NACHT-LRR proteins (NLRs) in bacterial infection and immunity,” Trends in Microbiology, vol. 13, no. 8, pp. 381–388, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  152. D. V. Koval'chuk, M. V. Khoreva, and A. S. Nikonova, “Recognition receptors of innate immunity (NLR, RLr, and CLR),” Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii, no. 1, pp. 93–100, 2011. View at Google Scholar
  153. M. Fukata, A. S. Vamadevan, and M. T. Abreu, “Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders,” Seminars in Immunology, vol. 21, no. 4, pp. 242–253, 2009. View at Publisher · View at Google Scholar · View at PubMed
  154. T. D. Kanneganti, M. Lamkanfi, and G. Núñez, “Intracellular NOD-like receptors in host defense and disease,” Immunity, vol. 27, no. 4, pp. 549–559, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  155. C. Ospelt, F. Brentano, A. Jüngel et al., “Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts,” Arthritis and Rheumatism, vol. 60, no. 2, pp. 355–363, 2009. View at Publisher · View at Google Scholar · View at PubMed
  156. L. A. B. Joosten, B. Heinhuis, S. Abdollahi-Roodsaz et al., “Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 9017–9022, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  157. W. Strober, P. J. Murray, A. Kitani, and T. Watanabe, “Signalling pathways and molecular interactions of NOD1 and NOD2,” Nature Reviews Immunology, vol. 6, no. 1, pp. 9–20, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  158. I. Ferreiros-Vidal, J. Garcia-Meijide, P. Carreira et al., “The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus,” Rheumatology, vol. 42, no. 4, pp. 570–574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  159. O. Hitotsumatsu, R. C. Ahmad, R. Tavares et al., “The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals,” Immunity, vol. 28, no. 3, pp. 381–390, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. R. R. Graham, C. Cotsapas, L. Davies et al., “Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 9, pp. 1059–1061, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  161. S. L. Musone, K. E. Taylor, T. T. Lu et al., “Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 9, pp. 1062–1064, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  162. J. W. Han, H. F. Zheng, Y. Cui et al., “Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus,” Nature Genetics, vol. 41, no. 11, pp. 1234–1237, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  163. I. Adrianto, F. Wen, A. Templeton et al., “Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus,” Nature Genetics, vol. 43, no. 3, pp. 253–258, 2011. View at Publisher · View at Google Scholar · View at PubMed
  164. A. J. van Beelen, Z. Zelinkova, E. W. Taanman-Kueter et al., “Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells,” Immunity, vol. 27, no. 4, pp. 660–669, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  165. S. L. Yu, C. K. Wong, P. T. Wong et al., “Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production,” PLoS One, vol. 6, no. 8, Article ID e23855, 2011. View at Google Scholar
  166. L. S. Tam, P. K. S. Chan, S. C. Ho et al., “Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: a prospective cohort study,” Arthritis Care and Research, vol. 63, no. 2, pp. 269–276, 2011. View at Publisher · View at Google Scholar · View at PubMed
  167. L. S. Tam, E. K. Li, S. M. Wong, and C. C. Szeto, “Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong,” Scandinavian Journal of Rheumatology, vol. 31, no. 5, pp. 296–300, 2002. View at Publisher · View at Google Scholar · View at Scopus
  168. L. S. Tam, A. Y. Chan, P. K. Chan, A. R. Chang, and E. K. Li, “Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3619–3625, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  169. L. S. Tam, P. K. S. Chan, S. C. Ho et al., “Natural history of cervical papilloma virus infection in systemic lupus erythematosus—a prospective cohort study,” Journal of Rheumatology, vol. 37, no. 2, pp. 330–340, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  170. S. E. Sweeney and G. S. Firestein, “Signal transduction in rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 16, no. 3, pp. 231–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  171. M. J. Thiel, C. J. Schaefer, M. E. Lesch et al., “Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms,” Arthritis and Rheumatism, vol. 56, no. 10, pp. 3347–3357, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  172. J. A. Bubier, S. M. Bennett, T. J. Sproule et al., “Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus,” Annals of the New York Academy of Sciences, vol. 1110, pp. 590–601, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  173. B. Zheng, Z. Ozen, X. Zhang et al., “CXCL13 neutralization reduces the severity of collagen-induced arthritis,” Arthritis and Rheumatism, vol. 52, no. 2, pp. 620–626, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  174. W. U. Kim, A. Sreih, and R. Bucala, “Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention,” Autoimmunity Reviews, vol. 8, no. 3, pp. 204–208, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  175. F. J. Barrat and R. L. Coffman, “Development of TLR inhibitors for the treatment of autoimmune diseases,” Immunological Reviews, vol. 223, no. 1, pp. 271–283, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus